Skip to main content

23 OCTOBER, 2012

bioMérieux - Business Review for the nine months ended September 30, 2012

Sales

  • Up 7.5% at constant exchange rates
  • Of which 3.2%* organic growth

Confirmed strong momentum in emerging markets

  • 28% of consolidated sales
  • 17%* organic growth